Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial Pain
Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial Pain
Recruiting · NCT04930887 · Registry updated 2026-04-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial Pain | Craniofacial Pain, Facial Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Stomatognathic Diseases, brain disorder, central nervous system disorder, cluster headache syndrome, cranial nerve neuropathy, facial nerve disorder, facial neuralgia, headache disorder, hypnic headache, migraine disorder, mouth disorder, nervous system disorder, paroxysmal Hemicrania, trigeminal autonomic cephalalgia | Recruiting | Phase 2 | 2026-04-27 | NCT04930887 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Stanford University | 620 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Peter H Hwang | Stanford | United States | 1 |